AI assistant
NUTRITIONAL GROWTH SOLUTIONS LTD — Capital/Financing Update 2025
Nov 27, 2025
65418_rns_2025-11-27_2fc48f12-7192-4ef9-92ff-e2f6cf96cdf4.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
AASX ANNOUNCEMENT | 28 NOVEMBER 2025
==> picture [86 x 51] intentionally omitted <==
Interim Loan Facility from Director
Nutritional Growth Solutions Limited (ASX: NGS) (“NGS" or the “Company”) advises that it has entered into an interim loan facility with a director of the Company ( Loan Facility ) to provide shortterm working capital pending receipt of funds from the A$2.0 million placement announced on 3 November 2025.
Loan Facility Key Terms
-
Lender: Andrew Grover (a director of the Company).
-
Date of agreement: 13 November 2025.
-
Total facility limit: A$250,000.
-
Amount drawn: A$80,000 as at the date of this announcement.
-
Interest: 0% per annum (no interest is payable on amounts drawn).
-
Maturity / repayment: Principal outstanding is repayable in full on or before 31 March 2026.
-
Security: Loan is unsecured.
-
Purpose: To provide short-term working capital for the Company pending receipt of placement proceeds
The Company may repay all or part of the amounts drawn under the Loan Facility at any time prior to maturity without penalty.
No securities, options or other equity-based incentives have been or will be issued to the director in connection with the Loan Facility.
Current Cash Position
The Company advises that:
-
cash at bank sits at approximately US$35,000; and
-
access to an approved temporary facility, with A$170,000 is currently available out of a total A$250,000 (A$80,000 already drawn).
The proposed A$2.0 million placement is subject to shareholder approval at the 23 December 2025 General Meeting and, if approved and completed, the funds are expected to be received shortly afterwards significantly improving its cash position.
This announcement has been authorised for release by the Board of Nutritional Growth Solutions Limited.
This announcement has been authorised for release by the Board of Directors of Nutritional Growth Solutions Ltd.
For further information, please contact:
Stephen Turner Managing Director and CEO
Nutritional Growth Solutions Ltd. | ASX Code: NGS | ARBN: 642 861 774 | www.ngsolutions.co Israel: 3 Hanechoshet Street, Tel Aviv 6423806 | Australia (Registered Local Agent): C/- Level 5, 126 Phillip Street, Sydney NSW 2000
AASX ANNOUNCEMENT | 28 NOVEMBER 2025
==> picture [86 x 51] intentionally omitted <==
About Nutritional Growth Solutions
Nutritional Growth Solutions is a U.S.-based health, nutrition, and wellness company. NGS develops, produces and sells clinically tested nutritional supplement formula for children following 20 years of medical research into pediatric nutrition. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three to twelve-year-old consumers represent a larger market opportunity and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.
https://healthyheights.com | https://ngsolutions.co
Nutritional Growth Solutions Ltd. | ASX Code: NGS | ARBN: 642 861 774 | www.ngsolutions.co Israel: 3 Hanechoshet Street, Tel Aviv 6423806 | Australia (Registered Local Agent): C/- Level 5, 126 Phillip Street, Sydney NSW 2000